Additional file 5 of Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma

MLA

Dumond, Aurore, et al. Additional File 5 of Neuropilin 1 and Neuropilin 2 Gene Invalidation or Pharmacological Inhibition Reveals Their Relevance for the Treatment of Metastatic Renal Cell Carcinoma. Jan. 2021. EBSCOhost, https://doi.org/10.6084/m9.figshare.13605733.

APA

Dumond, A., Brachet, E., Durivault, J., Vial, V., Puszko, A. K., Lepelletier, Y., Montemagno, C., Pagnuzzi-Boncompagni, M., Hermine, O., Garbay, C., Lagarde, N., Montes, M., Demange, L., Grépin, R., & Pagès, G. (2021). Additional file 5 of Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma. https://doi.org/10.6084/m9.figshare.13605733

Chicago

Dumond, Aurore, Etienne Brachet, Jérôme Durivault, Valérie Vial, Anna K. Puszko, Yves Lepelletier, Christopher Montemagno, et al. 2021. “Additional File 5 of Neuropilin 1 and Neuropilin 2 Gene Invalidation or Pharmacological Inhibition Reveals Their Relevance for the Treatment of Metastatic Renal Cell Carcinoma,” January. doi:10.6084/m9.figshare.13605733.